Paragon (ANZGOG-0903): Phase 2 Study of Anastrozole in Women With Estrogen or Progesterone Receptor–Positive Platinum-Resistant or -Refractory Recurrent Ovarian Cancer
Anthony Bonaventura, Rachel L. O'Connell, Cristina Mapagu, Philip J. Beale, Orla M. McNally, Linda R. Mileshkin, Peter T. Grant, Alison M. Hadley, Jeffery C.H. Goh, Katrin M. Sjoquist, Julie Martyn, Anna DeFazio, James Scurry, Michael L. Friedlander
International Journal of Gynecologic Cancer Jun 2017, 27 (5) 900-906; DOI: 10.1097/IGC.0000000000000978
